KULR Technology (KULR) 10-Q 1 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Oct. 29, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Registrant Name	KULR Technology Group, Inc.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Central Index Key	0001662684
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		81,071,831

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash	$ 76,061	$ 229,896
Accounts receivable	395,706	112,224
Inventory	43,645	9,594
Prepaid expenses	35,344	27,033
Other current assets	37,389	27,569
Total Current Assets	588,145	406,316
Property and equipment, net	35,347	44,791
Total Assets	623,492	451,107
Current Liabilities:
Accounts payable	332,749	117,995
Accrued expenses and other current liabilities	547,553	374,330
Accrued expenses and other current liabilities - related party	18,919	83,919
Total Current Liabilities	899,221	576,244
Commitments and contingencies (See Note 8)
Stockholders' Deficiency:
Common stock, $0.0001 par value, 500,000,000 shares authorized; 81,071,831 and 78,706,256 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	8,107	7,871
Additional paid-in capital	7,587,365	6,283,548
Accumulated deficit	(7,871,202)	(6,416,559)
Total Stockholders' Deficiency	(275,729)	(125,137)
Total Liabilities and Stockholders' Deficiency	623,492	451,107
Series A Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock	0	0
Series B Convertible Preferred Stock
Stockholders' Deficiency:
Total Stockholders' Deficiency	1	3
Series B Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock	1	3
Series C Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Preferred Stock, Par Value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Common Stock, Par Value (in dollars per share)	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	81,071,831	78,706,256
Common Stock, Shares Outstanding	81,071,831	78,706,256
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized	31,000	31,000
Preferred Stock, Shares Issued	14,487	30,858
Preferred Stock, Shares Outstanding	14,487	30,858
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized	400	400
Preferred Stock, Shares Issued	20.68	0
Preferred Stock, Shares Outstanding	20.68	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 526,722	$ 482,798	$ 777,984	$ 881,929
Cost of revenue	109,051	75,384	199,118	258,801
Gross Profit	417,671	407,414	578,866	623,128
Operating Expenses:
Research and development	137,970	161,194	365,709	399,884
Selling, general and administrative	546,982	461,377	1,666,735	1,908,635
Total Operating Expenses	684,952	622,571	2,032,444	2,308,519
Loss From Operations	(267,281)	(215,157)	(1,453,578)	(1,685,391)
Other (Expense) Income:
Interest expense, net	(503)	(269)	(1,315)	(502)
Other Income	250	0	250
Change in fair value of accrued issuable equity	0	24,175	0	24,175
Total Other (Expense) Income	(253)	23,906	(1,065)	23,673
Net Loss	$ (267,534)	$ (191,251)	$ (1,454,643)	$ (1,661,718)
Net Loss Per Share - Basic and Diluted (In dollars per share)	$ 0	$ 0	$ (0.02)	$ (0.02)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted (In Shares)	80,380,640	77,785,191	79,803,396	77,513,560

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) - USD ($)	Series B Convertible Preferred Stock	Series C Convertible Preferred Stock	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017			$ 7,744	$ 5,090,282	$ (4,358,320)	$ 739,706
Balance (shares) at Dec. 31, 2017			77,440,000
Stock-based compensation			$ 0	182,957	0	182,957
Stock-based compensation (in shares)			0
Net loss			$ 0	0	(825,845)	(825,845)
Balance at Mar. 31, 2018			$ 7,744	5,273,239	(5,184,165)	96,818
Balance (shares) at Mar. 31, 2018			77,440,000
Balance at Dec. 31, 2017			$ 7,744	5,090,282	(4,358,320)	739,706
Balance (shares) at Dec. 31, 2017			77,440,000
Net loss						(1,661,718)
Balance at Sep. 30, 2018			$ 7,802	5,750,416	(6,020,038)	(261,820)
Balance (shares) at Sep. 30, 2018			78,021,819
Balance at Mar. 31, 2018			$ 7,744	5,273,239	(5,184,165)	96,818
Balance (shares) at Mar. 31, 2018			77,440,000
Stock-based compensation			$ 0	124,835	0	124,835
Stock-based compensation (in shares)			0
Net loss			$ 0	0	(644,622)	(644,622)
Balance at Jun. 30, 2018			$ 7,744	5,398,074	(5,828,787)	(422,969)
Balance (shares) at Jun. 30, 2018			77,440,000
Common stock issued for cash			$ 58	352,342	0	352,400
Common stock issued for cash (in shares)			581,819
Net loss			$ 0	0	(191,251)	(191,251)
Balance at Sep. 30, 2018			$ 7,802	5,750,416	(6,020,038)	(261,820)
Balance (shares) at Sep. 30, 2018			78,021,819
Balance at Dec. 31, 2018	$ 3	$ 0	$ 7,871	6,283,548	(6,416,559)	(125,137)
Balance (shares) at Dec. 31, 2018	30,858	0	78,706,256
Stock-based compensation	$ 0	$ 0	$ 3	36,057	0	36,060
Stock-based compensation (in shares)	0	0	25,000
Common stock issued for cash	$ 0	$ 0	$ 23	154,977	0	155,000
Common stock issued for cash (in shares)	0	0	234,849
Net loss	$ 0	$ 0	$ 0	0	(565,693)	(565,693)
Balance at Mar. 31, 2019	$ 3	$ 0	$ 7,897	6,474,582	(6,982,252)	(499,770)
Balance (shares) at Mar. 31, 2019	30,858	0	78,966,105
Balance at Dec. 31, 2018	$ 3	$ 0	$ 7,871	6,283,548	(6,416,559)	(125,137)
Balance (shares) at Dec. 31, 2018	30,858	0	78,706,256
Net loss						(1,454,643)
Balance at Sep. 30, 2019	$ 1	$ 0	$ 8,107	7,587,365	(7,871,202)	(275,729)
Balance (shares) at Sep. 30, 2019	14,487	20.68	81,071,831
Balance at Mar. 31, 2019	$ 3	$ 0	$ 7,897	6,474,582	(6,982,252)	(499,770)
Balance (shares) at Mar. 31, 2019	30,858	0	78,966,105
Stock-based compensation	$ 0	$ 0	$ 0	7,593	0	7,593
Common stock issued for cash	0	0	$ 112	743,188	0	743,300
Common stock issued for cash (in shares)			1,126,210
Net loss	0	0	$ 0	0	(621,416)	(621,416)
Balance at Jun. 30, 2019	$ 3	$ 0	$ 8,009	7,225,363	(7,603,668)	(370,293)
Balance (shares) at Jun. 30, 2019	30,858	0	80,092,315
Stock-based compensation	$ 0	$ 0	$ 16	188,082	0	188,098
Stock-based compensation (in shares)	0	0	160,966
Series B Convertible Preferred Stock issued to common stockholders	$ (2)	$ 0	$ 82	(80)	0	0
Series B Convertible Preferred Stock issued to common stockholders (in shares)	(16,371)	0	818,550
Series C Convertible Preferred Stock and warrants issued for cash, net of issuance costs [1] (In Shares)	0	20.68	0
Series C Convertible Preferred Stock and warrants issued for cash, net of issuance costs [1]	$ 0	$ 0	$ 0	139,000	0	139,000
Forgiveness of accrued expenses by related party	0	0	0	35,000	0	35,000
Net loss	0	0	0	0	(267,534)	(267,534)
Balance at Sep. 30, 2019	$ 1	$ 0	$ 8,107	$ 7,587,365	$ (7,871,202)	$ (275,729)
Balance (shares) at Sep. 30, 2019	14,487	20.68	81,071,831

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (Parenthetical)	9 Months Ended
	Sep. 30, 2018USD ($)
Payments of Stock Issuance Costs	$ 0
Common Stock [Member]
Gross Proceeds From Issuance Of Common Stock	384,000
Payments of Stock Issuance Costs	31,600
Cash [Member] | Common Stock [Member]
Payments of Stock Issuance Costs	25,000
Non Cash [Member] | Common Stock [Member]
Payments of Stock Issuance Costs	$ 6,600

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018
Cash Flows From Operating Activities:
Net loss		$ (1,454,643)	$ (1,661,718)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		9,444	11,824
Change in fair value of accrued issuable equity		0	(24,175)
Write-down of inventory		90
Stock-based compensation		231,751	402,656
Changes in operating assets and liabilities:
Accounts receivable		(283,482)	(3,638)
Inventory		(34,141)
Prepaid expenses		(8,311)	23,733
Other current assets		(9,820)	(2,362)
Accounts payable		214,754
Accrued expenses and other current liabilities		158,223	216,267
Accrued expenses and other current liabilities - related party		(30,000)	(78,680)
Deferred revenue		0	51,158
Total Adjustments		248,508	596,783
Net Cash Used In Operating Activities		(1,206,135)	(1,064,935)
Cash Flows From Investing Activities:
Purchases of property and equipment		0	(15,476)
Net Cash Used In Investing Activities		0	(15,476)
Cash Flows From Financing Activities:
Proceeds from sale of Series C Convertible Preferred Stock and warrants [1]	[1]	169,000	0
Proceeds from sale of common stock [2]	[2]	898,300	359,000
Payment of deferred offering costs		(15,000)	0
Net Cash Provided By Financing Activities		1,052,300	359,000
Net Decrease In Cash		(153,835)	(721,411)
Cash - Beginning of Period		229,896	895,761
Cash - End of Period		76,061	174,350
Cash paid during the period for:
Interest		446	646
Income taxes		0	2,400
Non-cash investing and financing activities:
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction		0	6,600
Accrual of deferred offering costs		15,000	0
Common stock issued upon conversion of Series B Convertible Preferred Stock		82	0
Forgiveness of accrued expenses by related party		$ 35,000	$ 0
[1]	Includes gross proceeds of $186,000, less cash issuance costs of $17,000.
[2]	Includes gross proceeds of $384,000, less withheld issuance costs of $25,000 for the nine months ended September 30, 2018. There were no issuance costs for the nine months ended September 30, 2019.

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018
Payments of Stock Issuance Costs		$ 15,000	$ 0
Common Stock [Member]
Gross Proceeds From Issuance Of Common Stock		898,300	384,000
Payments of Stock Issuance Costs		0	31,600
Common Stock [Member] | Series C Convertible Preferred Stock
Gross Proceeds From Issuance Of Common Stock	$ 186,000	186,000
Cash [Member] | Common Stock [Member]
Payments of Stock Issuance Costs			$ 25,000
Cash [Member] | Common Stock [Member] | Series C Convertible Preferred Stock
Payments of Stock Issuance Costs	$ 17,000	$ 17,000

Business Organization, Nature o

Business Organization, Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Business Organization, Nature of Operations and Basis of Presentation
Business Organization, Nature of Operations and Basis of Presentation	Note 1 Business Organization, Nature of Operations and Basis of Presentation Organization and Operations KULR Technology Group, Inc., through its wholly-owned subsidiary, KULR Technology Corporation (collectively referred to as “KULR” or the “Company”), develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components across a range of applications. Currently, the Company is focused on targeting the following applications: electric vehicles and autonomous driving systems (collectively referred to herein as “E-Mobility”); artificial intelligence and Cloud computing; energy storage; and 5G communication technologies. KULR provides heat management solutions to enhance the performance and safety of battery packs used in electric vehicles, communication devices, and aerospace and defense applications. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10‑Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the operating results for the full year ending December 31, 2019 or any other period. These condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related disclosures as of December 31, 2018 and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10‑K on March 29, 2019.

Going Concern and Management's

Going Concern and Management's Plans	9 Months Ended
	Sep. 30, 2019
Going Concern and Management's Plans
Going Concern and Management's Plans	Note 2 Going Concern and Management’s Plans The Company has not yet achieved profitability and expects to continue to incur cash outflows from operations. It is expected that its research and development and general and administrative expenses will continue to increase and, as a result, the Company will eventually need to generate significant product revenues to achieve profitability. These raise substantial doubt about the Company’s ability to continue as a going concern within one year after the financial statement issuance date. The Company is currently funding its operations on a month-to-month basis by means of private placements. Although the Company’s management believes that it has access to capital resources, there are currently no commitments in place for new financing at this time and there is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. If the Company is unable to obtain adequate funds on reasonable terms, it may be required to significantly curtail or discontinue operations or obtain funds by entering into financing agreements on unattractive terms. The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustment that might become necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies.
Summary of Significant Accounting Policies	Note 3 Summary of Significant Accounting Policies Since the date of the Annual Report on Form 10‑K for the year ended December 31, 2018, there have been no material changes to the Company’s significant accounting policies, except as disclosed in this note. Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and accounts receivable. A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were no uninsured cash balances as of September 30, 2019 and December 31, 2018. Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2019 December 31, 2018 2019 2018 2019 2018 Customer A 67 % 92 % 46 % 64 % 90 % 63 % Customer B 14 % * 10 % * * * Customer C * * 15 % * * * Customer D * * * 17 % * * Customer E * * * 12 % * * Customer F * * * * * 37 % Total 82 % 92 % 71 % 93 % 90 % 100 % * There is no assurance the Company will continue to receive significant revenues from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: · Step 1: Identify the contract with the customer; · Step 2: Identify the performance obligations in the contract; · Step 3: Determine the transaction price; · Step 4: Allocate the transaction price to the performance obligations in the contract; and · Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: · Product sales – Revenue is recognized at the point the customer obtains controls of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. · Contract services – Revenue is recognized at the point in time that the Company satisfies its performance obligation under the contract, which is generally at the time it delivers a report to the customer. The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Product sales $ 464,772 $ 482,798 $ 686,522 $ 735,941 Contract services 61,950 — 91,462 145,988 Total revenue $ 526,722 $ 482,798 $ 777,984 $ 881,929 As of September 30, 2019 and December 31, 2018, the Company did not have any contract assets or contract liabilities from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract. During the three and nine months ended September 30, 2019 and 2018, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods. Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of non-vested restricted stock, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Series B Convertible Preferred Stock 724,350 — 724,350 — Series C Convertible Preferred Stock 206,800 — 206,800 — Options 400,000 — 400,000 — Warrants 201,700 — 201,700 — Total 1,532,850 — 1,532,850 — Operating Leases The Company leases properties under operating leases. For leases in effect upon adoption of Accounting Standards Update (“ASU”) 2016‑02, “Leases (Topic 842)” at January 1, 2019 and for any leases commencing thereafter, the Company recognizes a liability to make lease payments, the “lease liability”, and an asset representing the right to use the underlying asset during the lease term, the “right-of-use asset”. The lease liability is measured at the present value of the remaining lease payments, discounted at the Company’s incremental borrowing rate. The right-of-use asset is measured at the amount of the lease liability adjusted for the remaining balance of any lease incentives received, any cumulative prepaid or accrued rent if the lease payments are uneven throughout the lease term, any unamortized initial direct costs, and any impairment of the right-of-use-asset. Operating lease expense consists of a single lease cost calculated so that the remaining cost of the lease is allocated over the remaining lease term on a straight-line basis, variable lease payments not included in the lease liability, and any impairment of the right-of-use asset. The Company evaluated their operating leases and elected to apply the short-term lease measurement and recognition exemption in which the right of use assets and lease liabilities are not recognized for short-term leases. Recently Issued Accounting Pronouncements In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections - Amendments to SEC Paragraphs Pursuant to SEC Final Rule Releases No. 33-10532, Disclosure Update and Simplification, and Nos. 33-10231 and 33-10442, Investment Company Reporting Modernization and Miscellaneous Updates (SEC Update)" ("ASU 2019-07"). ASU 2019-07 aligns the guidance in various SEC sections of the Codification with the requirements of certain SEC final rules. ASU 2019-07 is effective immediately. The adoption of ASU 2019-07 did not have a material impact on the Company's unaudited condensed consolidated financial statements.

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2019
Accrued Expenses and Other Current Liabilities
Accrued Expenses and Other Current Liabilities	Note 4 Accrued Expenses and Other Current Liabilities As of September 30, 2019 and December 31, 2018, accrued expenses and other current liabilities consisted of the following: September 30, December 31, 2019 2018 (unaudited) Payroll and vacation $ 459,259 $ 252,043 Legal and professional fees 45,500 47,502 Travel expenses 20,812 48,248 Payroll and income tax payable 7,818 12,678 Research and development expenses — 2,850 Credit card payable 4,835 4,586 Accrued issuable equity — 3,960 Rent 176 176 Other 9,153 2,287 Total accrued expenses and other current liabilities $ 547,553 $ 374,330

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions
Related Party Transactions	Note 5 Related Party Transactions Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities – related parties consist of a liability of $18,919 and $83,919 as of September 30, 2019 and December 31, 2018, respectively, to Energy Science Laboratories, Inc. (“ESLI”), a company controlled by the Company’s Chief Technology Officer (“CTO”), in connection with consulting services provided to the Company associated with the development of the Company’s CFV thermal management solutions. On September 30, 2019, ESLI agreed to forgive $35,000 of previously accrued consulting fees. As a result, the Company accounted for the forgiveness as a capital contribution by reducing accrued expenses and other current liabilities by $35,000 with a corresponding credit to additional paid-in capital.

Stockholders' Deficiency

Stockholders' Deficiency	9 Months Ended
	Sep. 30, 2019
Stockholders' Deficiency
Stockholders' Deficiency	Note 6 Stockholders’ Deficiency Common Stock During the nine months ended September 30, 2019, the Company sold an aggregate of 1,361,059 shares of common stock at $0.66 per share to accredited investors for aggregate cash proceeds of $898,300. Series B Convertible Preferred Stock During the nine months ended September 30, 2019, holders of Series B Convertible Preferred Stock elected to convert an aggregate of 16,371 shares of Series B Convertible Preferred Stock into an aggregate of 818,550 shares of common stock. Series C Convertible Preferred Stock On August 19, 2019, the Company filed with the Secretary of State of the State of Delaware the Certificate of Designation of Series C Convertible Preferred Stock (the "Certificate of Designation"), which became effective upon filing. Pursuant to the Certificate of Designation, the Company designated 400 shares as Series C Convertible Preferred Stock out of the authorized and unissued preferred stock of the Company, par value $0.0001 per share. Series C Convertible Preferred Stock is senior in liquidation preference to the Company's common stock for an amount equal to the stated value per share of $10,000 ("Stated Value"). Holders of shares of Series C Convertible Preferred Stock shall vote on an as-if-converted-to-common-stock basis with the common stock. Holders of shares of Series C Convertible Preferred Stock are entitled to receive dividends when, as and if declared by the Board of Directors, at an annual rate of twelve percent (12)% beginning one year after each share's issuance. The Company may elect to redeem all or part of each share of Series C Convertible Preferred Stock for the Stated Value. Each share of Series C Convertible Preferred Stock, if converted within 180 days of such share's initial issuance, is convertible into a number of shares of common stock equal to the product determined by dividing (i) the Stated Value of the number of shares of Series C Convertible Preferred Stock being converted and any accrued dividends thereon and (ii) $1.00 per share. Each share of Series C Convertible Preferred Stock, if converted on or after the 181st day of its initial issuance, is convertible into a number of shares of common stock equal to the product determined by dividing (i) the Stated Value of the number of shares of Series C Convertible Preferred Stock being converted and any accrued dividends thereon and (ii) 75% of the average of the trading prices five days prior to conversion but in no case less than $0.90 per share. In addition, all outstanding shares of Series C Convertible Preferred Stock may be automatically converted upon the occurrence of a qualified offering of at least $5 million of gross proceeds ("Qualified Offering") or an approved listing of common stock on a national stock exchange ("Uplisting"). In the event of a Qualified Offering, each share of Series C Convertible Preferred Stock would be converted into a number of shares of common stock equal to the product determined by dividing (i) the Stated Value of the number of shares of Series C Convertible Preferred Stock being converted and any accrued dividends thereon and (ii) 85% of the price of the securities sold in the Qualified Offering. In the event of an Uplisting, each share of Series C Convertible Preferred Stock would be converted into a number of shares of common stock equal to the product determined by dividing (i) the Stated Value of the number of shares of Series C Convertible Preferred Stock being converted and any accrued dividends thereon and (ii) if converted within 180 days of such share's initial issuance, $1.00 per share, and if converted on or after the 181st day of its initial issuance, 75% of the average of the trading prices five days prior to conversion but in no case less than $0.90 per share. During the three months ended September 30, 2019, the Company sold to certain investors an aggregate of 20.68 shares of Series C Convertible Preferred Stock and two-year immediately vested warrants to purchase an aggregate of 51,700 shares of the Company's common stock at an exercise price of $1.50 per share for aggregate gross proceeds of $186,000, less cash issuance costs of $47,000, for aggregate net proceeds of $139,000. The warrants, which were determined to be classified within stockholders' deficiency, had an aggregate issuance date fair value of $10,779. The Company has computed the fair value of warrants using the Black-Scholes pricing model with the following assumptions: risk free interest rate – 1.53% – 1.74%; expected term – 2 years, expected volatility – 97%, expected dividends – 0%. The Series C Convertible Preferred Stock is redeemable at the Company's option, therefore it has been classified within stockholders' deficiency on the condensed consolidated balance sheet. An overall analysis of its features performed by the Company determined that the Series C Convertible Preferred Stock was more akin to equity. As a result, while the embedded conversion option ("ECO") contained certain anti-dilution price protection mechanisms, since the ECO was clearly and closely related to the equity host, it was not required to be bifurcated and accounted for as a derivative liability under ASC 815. The Company determined that the Series C Convertible Preferred Stock did not contain a beneficial conversion feature, since the conversion price exceeded the estimated fair value of the Company's common stock as of the commitment date, except upon a conversion in the event of a Qualified Offering, which was determined to be a contingent beneficial conversion feature, which will be measured when the contingency is resolved and, if determined to be beneficial at such time, will be recognized. Stock-Based Compensation During the three and nine months ended September 30, 2019, the Company recognized stock-based compensation expense of $138,640 and $231,751 (which includes the issuance of 185,966 shares common stock for $133,660 of services provided), respectively, and during the three and nine months ended September 30, 2018, the Company recognized stock-based compensation expense of $94,864 and $402,656, respectively, related to restricted common stock, stock options and warrants, which are included within general and administrative expenses on the condensed consolidated statements of operations. As of September 30, 2019, there was $152,794 of unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period of 1.98 years.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases
Leases	Note 7 Leases The Company has two operating leases for real estate which have remaining terms that are less than one year. The Company elected not to recognize short-term leases on the balance sheet and all costs were recognized as selling, general and administrative expenses on the condensed consolidated statements of operations. For the three and nine months ended September 30, 2019, operating lease expense was $41,281 and $121,769, respectively. For the three and nine months ended September 30, 2018, operating lease expense was $40,373 and $87,039, respectively. As of September 30, 2019, the Company does not have any financing leases.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies.
Commitments and Contingencies	Note 8 Commitments and Contingencies Patent License Agreement On March 21, 2018, the Company entered into an agreement with the National Renewable Energy Laboratory (“NREL”) granting the Company an exclusive license to commercialize its patented Internal Short Circuit technology. The agreement shall be effective for as long as the licensed patents are enforceable, subject to certain early termination provisions specified in the agreement. In consideration, the Company agreed to pay to NREL the following: (i) a cash payment of $12,000 payable over one year, (ii) royalties ranging from 1.5% to 3.75% on the net sales price of the licensed products, as defined in the agreement, with minimum annual royalty payments ranging from $0 to $7,500. In addition, the Company shall use commercially reasonable efforts to bring the licensed products to market through a commercialization program that requires that certain milestones be met, as specified in the agreement. For the three and nine months ended September 30, 2019, the Company recorded royalties of $450 and $1,140, respectively, that were included within cost of revenues. There were no royalties earned during the three and nine months ended September 30, 2018. Securities Purchase Agreement On April 2, 2019, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the stockholders (the “Sellers”) holding 100% of the ownership interest in TECHTOM Co., Ltd. (“TECHTOM”), a Japanese limited liability company, pursuant to which the Company agreed to purchase from the Sellers, subject to the satisfaction of certain closing conditions, all ownership interests in TECHTOM and any and all claims, notes and other liabilities owed by TECHTOM to the Sellers (the “Acquisition”). On July 5, 2019, the Company entered into a Rescission and Termination Agreement (the “Termination Agreement”) with the Sellers (each Seller, individually, and the Company, a “Party” or collectively, the “Parties”) holding 100% of the ownership interest in TECHTOM to terminate the Purchase Agreement. Pursuant to the Termination Agreement, each of the Parties mutually agreed (i) to rescind and terminate the Purchase Agreement, relieving each Party of their respective duties and obligations arising under the Purchase Agreement; and (ii) to a general release of all other respective Parties from all claims arising out of the Purchase Agreement or the Termination Agreement. Each Party is responsible for all costs and expenses incurred by such Party in connection with the Purchase Agreement or the Termination Agreement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies.
Concentrations	Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and accounts receivable. A significant portion of the Company’s cash is held at one major financial institution. The Company has not experienced any losses in such accounts. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There were no uninsured cash balances as of September 30, 2019 and December 31, 2018. Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2019 December 31, 2018 2019 2018 2019 2018 Customer A 67 % 92 % 46 % 64 % 90 % 63 % Customer B 14 % * 10 % * * * Customer C * * 15 % * * * Customer D * * * 17 % * * Customer E * * * 12 % * * Customer F * * * * * 37 % Total 82 % 92 % 71 % 93 % 90 % 100 % * There is no assurance the Company will continue to receive significant revenues from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The following five steps are applied to achieve that core principle: · Step 1: Identify the contract with the customer; · Step 2: Identify the performance obligations in the contract; · Step 3: Determine the transaction price; · Step 4: Allocate the transaction price to the performance obligations in the contract; and · Step 5: Recognize revenue when the company satisfies a performance obligation. The Company recognizes revenue primarily from the following different types of contracts: · Product sales – Revenue is recognized at the point the customer obtains controls of the goods and the Company satisfies its performance obligation, which is generally at the time it ships the product to the customer. · Contract services – Revenue is recognized at the point in time that the Company satisfies its performance obligation under the contract, which is generally at the time it delivers a report to the customer. The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Product sales $ 464,772 $ 482,798 $ 686,522 $ 735,941 Contract services 61,950 — 91,462 145,988 Total revenue $ 526,722 $ 482,798 $ 777,984 $ 881,929 As of September 30, 2019 and December 31, 2018, the Company did not have any contract assets or contract liabilities from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract. During the three and nine months ended September 30, 2019 and 2018, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of non-vested restricted stock, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Series B Convertible Preferred Stock 724,350 — 724,350 — Series C Convertible Preferred Stock 206,800 — 206,800 — Options 400,000 — 400,000 — Warrants 201,700 — 201,700 — Total 1,532,850 — 1,532,850 —
Operating Leases	Operating Leases The Company leases properties under operating leases. For leases in effect upon adoption of Accounting Standards Update (“ASU”) 2016‑02, “Leases (Topic 842)” at January 1, 2019 and for any leases commencing thereafter, the Company recognizes a liability to make lease payments, the “lease liability”, and an asset representing the right to use the underlying asset during the lease term, the “right-of-use asset”. The lease liability is measured at the present value of the remaining lease payments, discounted at the Company’s incremental borrowing rate. The right-of-use asset is measured at the amount of the lease liability adjusted for the remaining balance of any lease incentives received, any cumulative prepaid or accrued rent if the lease payments are uneven throughout the lease term, any unamortized initial direct costs, and any impairment of the right-of-use-asset. Operating lease expense consists of a single lease cost calculated so that the remaining cost of the lease is allocated over the remaining lease term on a straight-line basis, variable lease payments not included in the lease liability, and any impairment of the right-of-use asset. The Company evaluated their operating leases and elected to apply the short-term lease measurement and recognition exemption in which the right of use assets and lease liabilities are not recognized for short-term leases.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections - Amendments to SEC Paragraphs Pursuant to SEC Final Rule Releases No. 33-10532, Disclosure Update and Simplification, and Nos. 33-10231 and 33-10442, Investment Company Reporting Modernization and Miscellaneous Updates (SEC Update)" ("ASU 2019-07"). ASU 2019-07 aligns the guidance in various SEC sections of the Codification with the requirements of certain SEC final rules. ASU 2019-07 is effective immediately. The adoption of ASU 2019-07 did not have a material impact on the Company's unaudited condensed consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies.
Schedules of concentrations of credit risk	Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2019 December 31, 2018 2019 2018 2019 2018 Customer A 67 % 92 % 46 % 64 % 90 % 63 % Customer B 14 % * 10 % * * * Customer C * * 15 % * * * Customer D * * * 17 % * * Customer E * * * 12 % * * Customer F * * * * * 37 % Total 82 % 92 % 71 % 93 % 90 % 100 % * There is no assurance the Company will continue to receive significant revenues from any of these customers. Any reduction or delay in operating activity from any of the Company’s significant customers, or a delay or default in payment by any significant customer, or termination of agreements with significant customers, could materially harm the Company’s business and prospects. As a result of the Company’s significant customer concentrations, its gross profit and results from operations could fluctuate significantly due to changes in political, environmental, or economic conditions, or the loss of, reduction of business from, or less favorable terms with any of the Company’s significant customers.
Schedule of revenue from external customers by products and services	The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Product sales $ 464,772 $ 482,798 $ 686,522 $ 735,941 Contract services 61,950 — 91,462 145,988 Total revenue $ 526,722 $ 482,798 $ 777,984 $ 881,929
Schedules of weighted average dilutive common shares because their inclusion would have been anti-dilutive	The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2019 2018 2019 2018 Series B Convertible Preferred Stock 724,350 — 724,350 — Series C Convertible Preferred Stock 206,800 — 206,800 — Options 400,000 — 400,000 — Warrants 201,700 — 201,700 — Total 1,532,850 — 1,532,850 —

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2019
Accrued Expenses and Other Current Liabilities
Schedule of accrued expenses and other current liabilities	As of September 30, 2019 and December 31, 2018, accrued expenses and other current liabilities consisted of the following: September 30, December 31, 2019 2018 (unaudited) Payroll and vacation $ 459,259 $ 252,043 Legal and professional fees 45,500 47,502 Travel expenses 20,812 48,248 Payroll and income tax payable 7,818 12,678 Research and development expenses — 2,850 Credit card payable 4,835 4,586 Accrued issuable equity — 3,960 Rent 176 176 Other 9,153 2,287 Total accrued expenses and other current liabilities $ 547,553 $ 374,330

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Summary of Significant Accounting Policies.
Cash, FDIC Insured Amount	$ 250,000		$ 250,000
Revenue Recognized	$ 0	$ 0	$ 0	$ 0	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Customer concentrations (Details)		Dec. 31, 2018		Sep. 30, 2019		Sep. 30, 2018		Sep. 30, 2019		Sep. 30, 2018
Revenues [Member]
Concentration Risk, Percentage				82.00%		92.00%		71.00%		93.00%
Accounts Receivable [Member]
Concentration Risk, Percentage		100.00%						90.00%
Customer A [Member] | Revenues [Member]
Concentration Risk, Percentage				67.00%		92.00%	[1]	46.00%		64.00%
Customer A [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage		63.00%						90.00%	[1]
Customer B [Member] | Revenues [Member]
Concentration Risk, Percentage				14.00%			[1]	10.00%
Customer B [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			[1]
Customer C [Member] | Revenues [Member]
Concentration Risk, Percentage					[1]			15.00%
Customer C [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	[1]
Customer D [Member] | Revenues [Member]
Concentration Risk, Percentage					[1]		[1]			17.00%
Customer D [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage									[1]
Customer E [Member] | Revenues [Member]
Concentration Risk, Percentage					[1]					12.00%
Customer E [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	[1]
Customer F [Member] | Revenues [Member]
Concentration Risk, Percentage	[1]
Customer F [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage		37.00%	[1]
[1]	Less than 10%

Summary of Significant Accoun_6

Summary of Significant Accounting Policies- condensed consolidated statements of operations: (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Total revenue	$ 526,722	$ 482,798	$ 777,984	$ 881,929
Contract with Customer, Liability, Revenue Recognized	0	0	0	0	$ 0
Product sales [Member]
Total revenue	464,772	$ 482,798	686,522	735,941
Contract services [Member]
Total revenue	$ 61,950		$ 91,462	$ 145,988

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - weighted average dilutive common shares (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,532,850	0	1,532,850	0
Series B Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	724,350	0	724,350	0
Series C Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	206,800	0	206,800	0
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	400,000	0	400,000	0
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	201,700	0	201,700	0

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Accrued Expenses and Other Current Liabilities
Payroll and vacation	$ 459,259	$ 252,043
Legal and professional fees	45,500	47,502
Travel expenses	20,812	48,248
Payroll and income tax payable	7,818	12,678
Research and development expenses	0	2,850
Credit card payable	4,835	4,586
Accrued issuable equity	0	3,960
Rent	176	176
Other	9,153	2,287
Total accrued expenses and other current liabilities	$ 547,553	$ 374,330

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Due to Other Related Parties, Current	$ 18,919	$ 83,919
Adjustments to Additional Paid in Capital, Other	35,000
Chief Technology Officer CTO [Member]
Related Party Transaction [Line Items]
Due to Other Related Parties, Current	18,919	$ 83,919
Energy Science Laboratories, Inc ESLI [Member]
Related Party Transaction [Line Items]
Adjustments to Additional Paid in Capital, Other	$ 35,000

Stockholders' Deficiency (Detai

Stockholders' Deficiency (Details) - USD ($)		Aug. 19, 2019	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Preferred Stock, Par or Stated Value Per Share			$ 0.0001		$ 0.0001		$ 0.0001
Proceeds from Issuance of Preferred Stock and Preference Stock	[1]				$ 169,000	$ 0
Payments of Stock Issuance Costs					15,000	0
Proceeds from Issuance of Common Stock	[2]				898,300	359,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 152,794		$ 152,794
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year 11 months 23 days
Series B Convertible Preferred Stock
Conversion of Stock, Shares Converted					16,371
Convertible Preferred Stock, Shares Issued upon Conversion			818,550		818,550
Series C Convertible Preferred Stock
Convertible Preferred Stock, Shares Reserved for Future Issuance		400
Preferred Stock, Par or Stated Value Per Share		$ 0.0001
Preferred Stock, Liquidation Preference Per Share		$ 10,000
Preferred Stock, Dividend Rate, Percentage		12.00%
Proceeds from Issuance of Preferred Stock and Preference Stock		$ 5,000,000
Preferred Stock, Convertible, Conversion, Percentage of Securities Price		85.00%
Preferred Stock, Shares Issued			20.68		20.68
Series C Convertible Preferred Stock | Less than 180 Days [Member]
Preferred Stock, Convertible, Conversion Price Per Share		$ 1
Series C Convertible Preferred Stock | More than 180 Days [Member]
Preferred Stock, Convertible, Conversion Price Per Share		$ 0.90
Preferred Stock, Convertible, Conversion, Average of Trading Prices		75.00%
Preferred Stock, Convertible, Conversion, Threshold Days		5 days
Warrant
Warrants Not Settleable in Cash, Fair Value Disclosure			$ 10,779		$ 10,779
Expected term			2 years
Expected volatility			97.00%
Expected dividends			0.00%
Warrant | Minimum [Member]
Risk free interest rate			1.53%
Warrant | Maximum [Member]
Risk free interest rate			1.74%
General and Administrative Expense [Member]
Allocated Share-based Compensation Expense			$ 138,640	$ 94,864	$ 231,751	402,656
Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction					1,361,059
Sale of Stock, Price Per Share			$ 0.66		$ 0.66
Gross cash proceeds from common stock					$ 898,300	384,000
Payments of Stock Issuance Costs					$ 0	31,600
Stock Issued During Period, Shares, Issued for Services					185,966
Stock Issued During Period, Value, Issued for Services					$ 133,660
Common Stock [Member] | Cash [Member]
Payments of Stock Issuance Costs						$ 25,000
Common Stock [Member] | Series C Convertible Preferred Stock
Gross cash proceeds from common stock			$ 186,000		$ 186,000
Shares, Issued			51,700		51,700
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$ 1.50
Proceeds from Issuance of Common Stock			$ 139,000
Common Stock [Member] | Series C Convertible Preferred Stock | Cash [Member]
Payments of Stock Issuance Costs			$ 17,000		$ 17,000
[1]	Includes gross proceeds of $186,000, less cash issuance costs of $17,000.
[2]	Includes gross proceeds of $384,000, less withheld issuance costs of $25,000 for the nine months ended September 30, 2018. There were no issuance costs for the nine months ended September 30, 2019.

Leases (Details)

Leases (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)
Leases
Number of Operating Leases	2		2
Operating Lease, Weighted Average Remaining Lease Term	1 year		1 year
Operating Lease, Expense	$ 41,281	$ 40,373	$ 121,769	$ 87,039

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Jul. 05, 2019	Mar. 21, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Apr. 02, 2019
Royalty Expense			$ 450	$ 0	$ 1,140	$ 0
License [Member]
Consideration Cash Payment		$ 12,000
Minimum [Member]
Royalty Rate		1.50%
Payments for Royalties		$ 0
Maximum [Member]
Royalty Rate		3.75%
Payments for Royalties		$ 7,500
TECHTOM
Ownership interest (as a percent)							100.00%
Ownership interest terminated	100.00%